{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:44:45Z","timestamp":1793641485001,"version":"4.5.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","award":["20AA2005"],"award-info":[{"award-number":["20AA2005"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106790","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:11:23Z","timestamp":1759633883000},"page":"106790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hospital volume impact on multiple sclerosis outcomes: a retrospective cohort study using a nationwide administrative database in Japan"],"prefix":"10.1016","volume":"104","author":[{"given":"Hiromichi","family":"Otaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-0290","authenticated-orcid":false,"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2025.106790_bib0001","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/stats5020029","article-title":"The missing indicator approach for accelerated failure time model with covariates subject to limits of detection","volume":"5","author":"Alyabs","year":"2022","journal-title":"Stats"},{"issue":"2","key":"10.1016\/j.msard.2025.106790_bib0002","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/bimj.201900041","article-title":"Estimating treatment effects with partially observed covariates using outcome regression with missing indicators","volume":"62","author":"Blake","year":"2020","journal-title":"Biom. J."},{"issue":"7","key":"10.1016\/j.msard.2025.106790_bib0003","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/1352458516636474","article-title":"All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES","volume":"22","author":"Brownlee","year":"2016","journal-title":"Mult. Scler"},{"issue":"6","key":"10.1016\/j.msard.2025.106790_bib0004","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1474-4422(14)70049-3","article-title":"Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"13","author":"Calabresi","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106790_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12984-022-01075-7","article-title":"Cross-validation of predictive models for functional recovery after post-stroke rehabilitation","volume":"19","author":"Campagnini","year":"2022","journal-title":"J. Neuroeng. Rehabil."},{"issue":"1","key":"10.1016\/j.msard.2025.106790_bib0006","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"key":"10.1016\/j.msard.2025.106790_bib0007","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2025.106790_bib0008","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N Engl. J. Med."},{"issue":"1","key":"10.1016\/j.msard.2025.106790_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2188\/jea.JE20200288","article-title":"History and profile of diagnosis procedure combination (DPC): development of a real data collection system for acute inpatient care in Japan","volume":"31","author":"Hayashida","year":"2021","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.msard.2025.106790_bib0010","unstructured":"JSN. (2017). Japanese guidelines for multiple sclerosis and neuromyelitis optica. Retrieved 4 August 2024 from https:\/\/www.neurology-jp.org\/guidelinem\/koukasyo_onm_2017.html."},{"issue":"9485","key":"10.1016\/j.msard.2025.106790_bib0011","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2025.106790_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105349","article-title":"Dynamic changes in patient admission and their disabilities in multiple sclerosis and neuromyelitis optica: a Japanese nationwide administrative data study","volume":"81","author":"Matsumoto","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106790_bib0013","unstructured":"MHLW. (2022). Number of patients holding a certificate of designated intractable diseases. Japan Intractable Disease Information Center. Retrieved 28 July 2024 from https:\/\/www.nanbyou.or.jp\/entry\/5354."},{"issue":"9","key":"10.1016\/j.msard.2025.106790_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222012","article-title":"Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: comparison between centre-based and local service healthcare delivery","volume":"14","author":"Moccia","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.msard.2025.106790_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.0000000000002276","article-title":"Neurologist ambulatory care, health care utilization, and costs in a large commercial dataset","volume":"86","author":"Ney","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2025.106790_bib0016","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cen3.12411","article-title":"Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database","volume":"8","author":"Ogino","year":"2017","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.msard.2025.106790_bib0017","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2023-0016","article-title":"Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis","volume":"12","author":"Samjoo","year":"2023","journal-title":"J. Comp. Eff. Res."},{"issue":"10130","key":"10.1016\/j.msard.2025.106790_bib0018","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2025.106790_bib0019","unstructured":"WHO. (2024). Magnetic resonance imaging units (per million population), total density, the Global Health Observatory. Retrieved 4 August 2024 from https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/total-density-per-million-population-magnetic-resonance-imaging."},{"issue":"1\u20132","key":"10.1016\/j.msard.2025.106790_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7223\/apjdm.7.19","article-title":"Clinical Epidemiology and Health Services research using the Diagnosis Procedure Combination Database in Japan","volume":"7","author":"Yasunaga","year":"2015","journal-title":"Asian Pacific J. Dis. Manag."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:38:27Z","timestamp":1784345907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":20,"alternative-id":["S2211034825005322"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106790","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospital volume impact on multiple sclerosis outcomes: a retrospective cohort study using a nationwide administrative database in Japan","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106790"}}